IntroductIon
The management of type 2 diabetes (T2D) involves adopting and maintaining a variety of lifestyle and self-care behaviors including dietary, physical activity, glucose monitoring, and medication adherence that may be new for patients. 1 As glycemic control becomes more difficult with increasing duration of disease, treatment intensification involving additional medication, lifestyle changes, and monitoring is often recommended. These behavioral changes are inter-related and can result in ever-increasing complexity for the patient, potentially impacting quality of life. These complex behavioral changes may impact role functioning, a concern among African American women who often care for others in their family, often with limited social and financial support. Due to this increasing complexity and burden of self-care behaviors, many female patients experience increased emotional distress that has been reported in more than 40% of patients with T2D. [2] [3] [4] [5] This emotional distress related to diabetes has been associated with inadequate self-care behaviors, medication non-adherence, and poor glycemic control. 2, 3, 6 Diabetes-related distress has also been associated with an increased risk for depression in a longitudinal study of patients with diabetes. 7 Further, recent evidence from our prior work suggests that stress and depressive symptoms in patients with diabetes may be associated with a higher incidence of cardiovascular events and death, especially among African American women. 10 demonstrated that improving regimen-related distress in particular resulted in improved selfcare behaviors and glycemic control. In addition, the impact of a specific distress-reducing cognitive behavioral treatment program in European patients with diabetes and subclinical depression was recently described by Hermann et al, 11 demonstrating improvements in both measures of distress and depressive symptoms. However, self-care behaviors and glycemic control were not significantly improved despite improvement in the psychological measures. These results are conflicting and may relate to the nature of the intervention strategy and to the populations studied. Further, most prior studies of diabetes-related distress have occurred in large metropolitan communities with predominantly Caucasian populations and the potential impact of lowering distress levels has not been well-studied in rural African American women with T2D, a population with elevated levels of distress and different social support structures but also with potential strengths and resiliency. 12, 13 The purpose of our present study was to examine the impact of lowering diabetes-related emotional distress on glycemic control and associated behavioral correlates in at-risk rural African American women with uncontrolled T2D. Further, we examined if changes in diabetes-related distress were associated with changes in self-efficacy, self-care behaviors, or medication adherence as potential correlates of improvement in glycemic control.
Methods

Research Design
This study is a post-hoc analysis of a prospective, randomized, controlled trial, the EMPOWER study, to examine the impact of changes in diabetesrelated distress. The design and baseline characteristics of the EMPOWER diabetes study have been previously described. 12 Briefly, EMPOWER is a randomized prospective clinical trial of a peer advisor telephone-delivered 16-session small-changes lifestyle intervention (small self-determined nutrition and physical activity goals relative to baseline behaviors) and medication adherence support compared with a control group receiving mailed diabetes educational materials (number of mailings matched for the number of contacts), in adult African American women with uncontrolled T2D. The phone was chosen as the primary mode of intervention specifically because of the lack of transportation and distance to community centers noted in the three rural counties identified for our study. The peer advisor facilitated the development, implementation, and monitoring of specific small changes goals related to diet, physical activity, and medication adherence. Specific treatment topics addressed by the peer advisor included self-management behaviors that focus on portion control, sweetened beverage consumption, leisure time physical activity, medication adherence, self-monitoring of weight and blood sugar, stress management, and similar T2D management behaviors. The peer advisor-facilitated goal selection was designed to be relative to baseline behaviors (to emphasize lifestyle change), determined by the patient instead of externally set by staff (to optimize goal ownership and self-efficacy), and small and manageable to minimize the likelihood of feeling overwhelmed with goals that were "unreachable." The goal was to facilitate patients accumulating and sustaining a number of small lifestyle changes and improved health behaviors over time, resulting in weight reduction and improved glycemic control.
Sample and Setting
Patients recruited included adult (aged 18 -75 years) African American women with uncontrolled T2D (A1C ≥ 7.0%) and without end-stage complications/advanced disease (determined by self-report and medical records review). Study patients were recruited from both regional primary care medical practices and from community sites located in the rural southeastern United States. All patients signed a statement of informed consent that was approved by the study university's Institutional Review Board. The trial was registered with ClinicalTrials.gov [NCT01806194] . Only patients with complete data for all measures at all time points were included in our present study.
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Patients
Our present study included 129 patients from both treatment arms who had complete clinical and behavioral measures available at baseline and at all follow-up time points (ie, no missing data). This included 71 patients from the intervention arm (55%); and 58 patients from the control arm (45%). There were no major differences in baseline characteristics between this study sample with complete follow-up data and the larger enrollment sample.
Outcome Measures and Data Collection Procedures
The independent variable of interest was the change in diabetes-related distress, measured using the Diabetes Distress Scale developed by Polonsky et al. 4 Specifically, the Diabetes Distress Scale (DDS), a well-validated 17-item measure of disease-specific distress, 4 was administered at baseline and at 12-month follow-up via a face-to-face research visit in the community with one of the investigators. The mean distress scores and mean change from baseline to 12-month follow-up were computed. For example, the DDS asks respondents to rate the extent to which they "feel overwhelmed by the demands of living with diabetes," "feel they are often failing in their diabetes routine," and "don't feel confident in their day-to-day ability to manage their diabetes." The investigators also measured several potential correlates of change in glycemic control at the same baseline and 12-month followup visits including self-reported medication adherence, measured using the validated 8-item Morisky Medication Adherence Scale (MMAS-8).
14 Values for the MMAS-8 score were recoded as described by Morisky 14 to achieve a score ranging from 0 to 8, with higher scores indicative of greater medication adherence. Diabetes self-care behaviors were assessed and scored using the Summary of Diabetes Self-Care Activities measure, a validated instrument described by Toobert et al. 15 Empowerment and self-efficacy were assessed and scored via validated instruments including the Diabetes Empowerment Scale -Short Form, described by Anderson et al, 16 and by the Diabetes SelfEfficacy Scale, 17 respectively. Responses for each instrument were collected using paper and pencil surveys completed by the patient at each research visit. Change in A1C from baseline to 12-month follow-up was measured via fingerstick at the same research visits. (DCA Vantage, Siemens Healthcare Diagnostics, Inc., Tarrytown, NY)
Statistics
Sample size for this study was estimated using a two-tailed alpha of .05, a beta of .20, an effect size of .5, and a standard deviation of 1.0 resulting in a sample size needed of 63 patients per group (total n=126). The investigators examined the relationship between changes in diabetes-related distress (mean DDS score) and changes in A1C using various statistical comparisons. To facilitate an initial comparison of demographic, clinical and behavioral parameters at baseline only by distress level, patients were dichotomized as follows: those with a baseline mean DDS of ≥3.0 were considered to have elevated distress while patients with a mean DDS of <3.0 were considered to have a normal distress level. Demographic (education, income, employment, food assistance), clinical (A1C) and behavioral (self-care behaviors, self-efficacy, medication adherence) parameters at baseline were then compared in these two distress level groups using independent samples T-tests and Chi square comparisons. Mean changes in A1C and in mean DDS scores across time from baseline to 12-month follow-up were also initially evaluated as continuous measures using Pearson correlation analysis.
To characterize the associations with change in DDS scores from baseline to 12-month follow-up, all patients were subsequently dichotomized into two groups based on whether their diabetes-related distress improved vs worsened or stayed the same across the 12 months. Mean changes from baseline to 12-month follow-up in A1C, self-efficacy, selfcare behaviors, and medication adherence were then compared between the two dichotomized distress groups (distress improved vs worsened/stayed the same) using a student's T test. In addition, changes in the continuous measures for distress, self-efficacy, self-care behaviors, and medication adherence from baseline to 12-month follow-up were evaluated using Pearson correlation analysis. All data were analyzed using SPSS vs. 22 (IBM, Chicago, IL).
results
Baseline Parameters by Level of Distress
Approximately 35% of women (n=45) had elevated levels of diabetesrelated distress at baseline. Table 1 provides a comparison of demographic, clinical, and behavioral parameters at baseline for women with low/nor-
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mal levels of distress (< 3.0) vs those with elevated levels of distress (≥ 3.0). These findings demonstrate that those with elevated distress levels at baseline had significantly higher A1C values as well as significantly lower self-reported levels of self-care behaviors, selfefficacy, and medication adherence.
Changes in Distress and Corresponding Changes in Clinical and Behavioral Parameters
Seventy-nine of 129 (61%) women across both treatment arms improved their mean diabetes-related distress level between baseline and 12-month follow-up while 50 (39%) women had unchanged or worsened distress levels. There were no significant differences in baseline characteristics including mean A1C, age, duration of diabetes, education level, employment status, and annual income between those whose distress level improved vs those whose distress level stayed the same or worsened (data not shown). However, there was a significant difference in the change in A1C as shown in Figure 1 . In women whose distress declined, there was a mean reduction in A1C of .34 while in those whose distress stayed the same or worsened, A1C increased by an average of .2, leaving the 12-month endpoints an average of .55 apart (P=.05). This change was accompanied by significant changes in mean self-efficacy, self-care activities, empowerment, and medication adherence scores (Table 2) 
dIscussIon
Our present study highlights the critical nature of behavioral co-morbidities in chronic disease in a high-risk subset of African American women, a group with important disparities in diabetes-related morbidity and mortality. Further, this study is among the first to suggest that reduction in emotional distress in this high-risk population may be associated with important changes in A1C and the behavioral correlates of self-care. The study was conducted in a rural area in the southeastern United States with a sample of African American women with limited education and income and with a history of uncontrolled T2D; this group that has been inadequately studied in many reports. At baseline, elevated levels of diabetes-related distress were associated with higher A1C values and with lower levels of self-care behaviors, self-efficacy, and medication adherence, as we have previously reported. 6 The findings across 12 months of follow-up suggest a strong relationship between reduction in diabetes-related distress and improvements in glycemic control, regardless of the patient's randomly assigned intervention arm. Of note, patients whose diabetes-related distress stayed the same or worsened actually had a modest worsening of A1C at 12-month follow-up. The importance of addressing behavioral co-morbidities, such as diabetesrelated distress, are illustrated in our recent article in which patients with diabetes and elevated levels of stress 
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or depressive symptoms or both in the national REGARDS study were at substantially increased risk for adverse cardiovascular outcomes. 8 Of note, African American women represented the highest risk demographic group.
The exact mechanisms whereby elevated levels of diabetes-related distress are associated with higher A1C values and whereby reduction in diabetesrelated distress is associated with improvements in A1C remain to be fully elucidated. However, previous data have shown that elevated stress in diabetes results in increased cortisol levels that are associated with higher glucose concentrations. 18 Our present findings in a high-risk population of women suggest an important relationship between the reduction in diabetes-related distress and improvements in self-care activities, self-efficacy, and medication adherence. This suggests the possibility that therapeutic strategies to reduce diabetes-related distress may improve glycemic control in part through improving the patient's self-care behaviors, self-efficacy, and medication adherence. These findings add to those of Hessler et al 10 who also found a relationship between behavioral correlates of improved glycemic control in the context of reducing elevated levels of regimen-related distress. However, we acknowledge the potential for bi-directionality and that improvements in glycemic control may be followed by reductions in diabetes-related distress.
Our present study has some limitations. The study was undertaken in rural African American women in the southeastern United States and generalizability to other racial or geographic groups is not possible. The study was not powered to test the relationship between changes in distress and A1C using multivariate statistical analyses that might control for the independent effects of selected demographic and/or clinical variables. Despite this, our study suggests that diabetes-related emotional distress may be an important therapeutic target and suggests the need for further research in high-risk African American women with uncontrolled T2D.
These findings have important implications for the delivery of diabetes care in rural African American women. Specifically, these results suggest the need to not only screen for diabetes-related distress in rural primary care but to pursue additional trials regarding whether lowering elevated levels of diabetes-related distress might represent an important therapeutic target that is associated with not only improving behavioral outcomes but also glycemic control.
conclusIon
In conclusion, our study in rural African American women with uncontrolled T2D demonstrates that the lowering of diabetes-related distress 
